ScubaTx device will commercialise Persufflation, a tried-and-true but underutilised method of organ preservation.
ScubaTx has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
ScubaTx's investors include Praetura Ventures, Innovate UK, GM&C Life Sciences Fund.
ScubaTx is headquartered in Newcastle Upon Tyne, United Kingdom.
ScubaTx device will commercialise Persufflation, a tried-and-true but underutilised method of organ preservation.
ScubaTx is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ScubaTx — Funding & Investors." VCBacked, September 3, 2024, https://www.vcbacked.co/company/scubatx. Accessed July 19, 2026.
VCBacked. (2024). ScubaTx — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/scubatx
{{cite web |title=ScubaTx — Funding & Investors |url=https://www.vcbacked.co/company/scubatx |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated